| Mrs Kelli Raynel Beckman, | |
|
107 3rd Ave Se, Dickinson, ND 58601-5637 | |
| (701) 227-3010 | |
| (701) 225-1968 |
| Full Name | Mrs Kelli Raynel Beckman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 107 3rd Ave Se, Dickinson, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528210242 | NPI | - | NPPES |
| 55208 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1022 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kelli Raynel Beckman, Po Box 1057, Dickinson, ND 58602-1057 Ph: (701) 227-3010 | Mrs Kelli Raynel Beckman, 107 3rd Ave Se, Dickinson, ND 58601-5637 Ph: (701) 227-3010 |
News Archive
University of Adelaide research has produced a potential new antibiotic which could help in the battle against bacterial resistance to antibiotics.
The U.S. Preventive Services Task Force recommendation against regular prostate specific antigen (PSA) screening for prostate cancer is controversial. While it may reduce the risk of over diagnosis and overtreatment, the reduction in intermediate and high risk cancer diagnoses raises concern because of the potential for delayed diagnoses of important cancers in men who may benefit from treatment, according to investigators reporting in The Journal of Urology.
Among possible ways to resolve the continuing issues, state officials are contemplating the possibility of buying or leasing technology from states where the online insurance marketplace is working. They also are considering scrapping the current website and starting over. News outlets also track developments in Maryland, California and Illinois.
pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the positive top-line results reported in December 2009 by pSivida and its licensee, Alimera Sciences, Inc.
› Verified 1 days ago
Mrs. Yesenia Perez, M.A. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2615 Fairway St, Dickinson, ND 58601 Phone: 701-456-6000 | |
Leslie Johnson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 227 16th St W, Suite 100, Dickinson, ND 58601 Phone: 701-225-0767 Fax: 701-225-7123 | |
Karli Heiser, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 230 3rd Ave E, Dickinson, ND 58601 Phone: 701-456-0015 | |
Sara Bogotch, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 683 State Ave, Dickinson, ND 58601 Phone: 701-483-9400 | |
Lisette Michaels, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 683 State Ave N, Dickinson, ND 58601 Phone: 623-698-4742 | |
Merrill Fahlstrom, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 683 State Ave Ste B, Dickinson, ND 58601 Phone: 701-483-9400 Fax: 701-483-9398 | |
Mrs. Rhoda Ione Hilden, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 979 13th Ave W, Dickinson, ND 58601 Phone: 701-456-0030 Fax: 701-456-0019 |